The Engine for Functional Immune Cell Profiling and Receptor Discovery

We analyze, understand, and manipulate massive numbers of cells on the single cell level to develop more effective treatments for human diseases. 

Learn More

Powered by Our Proprietary Platform

Our proprietary ultra-high throughput single cell platform enables us to functionally profile millions of immune cells on the single cell level at the same time, pulling out rare and difficult-to-find targets that are like the needles in a haystack. This allows us to create immunotherapies that are more targeted and more effective. We are using this unique platform to first develop cell therapies for solid tumors. 

Learn more about our Technology

Centered around people

We believe that people are the key that drives scientific and organizational successes. We are dedicated to building an environment where everyone thrives. We have a culture of collaboration, ownership, and authenticity. We are proud to have built an interdisciplinary team that embodies this culture.   

Learn more about our Team
Shennon Bio team

Careers

We love working with great people and solving critical problems. Come join us.

Current openings

Research Associate

San Francisco, CA

Full Time

Computational Biologist

San Francisco, CA

Full Time

Senior Microfluidics Engineer

San Francisco, CA

Full Time

Scientist / Senior Scientist in Immunology

San Francisco, CA

Full Time

Director / VP of R&D

San Francisco, CA

Full Time

Leadership and Scientific Advisors

Li Sun, PhD

CEO & Founder

Former VC at Foundation Capital and Bessemer Venture Partners, PhD in Applied Physics from Harvard University

Learn More

Kaveh Milaninia, PhD

CTO & Head of Platform

Serial entrepreneur in life science tools, PhD in Materials Science from Massachusetts Institute of Technology

Learn More

David Weitz, PhD

Scientific Advisor

Expert in single cell platforms, Professor of Physics and Applied Physics

Learn More

Joseph Fraietta, PhD

Scientific Advisor

T cell therapy expert, Director of the Solid Tumor Immunotherapy Lab

Learn More

Benjamin Greenbaum, PhD

Scientific Advisor

Expert in neoantigen prediction, Computational Oncologist

Learn More

Niroshana Anandasabapathy, MD/PhD

Scientific Advisor

Melanoma expert, Associate Professor of Dermatology in Microbiology and Immunology

Learn More

Jonathan Esensten, MD/PhD

Scientific Advisor

Expert in cell therapy development and manufacturing, Medical Director of the GMP facility

Learn More

Paul Thomas, PhD

Scientific Advisor

T cell expert, Faculty in the Immunology Department

Learn More

Ian Chen, PhD

Staff Platform Engineer

Learn More

Nicole Lee

Platform Engineer

Learn More

Naomi Ptak

Operations Manager

Learn More

Kaitao Li, PhD

Principal Scientist

Learn More

Solenn Matuska

Research Associate

Learn More

Sandra Nielsen, PhD

Senior Scientist

Learn More

Michael Malone, PhD

Scientist

Learn More

Latest News

Mar 13, 2023

Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform

Read Article
Mar 13, 2023

Immunotherapy biotech unstealths with $13M; Anti-infection candidate for CF passes safety trial

Read Article
Mar 13, 2023

Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform

Read Article
Mar 15, 2023

How a onetime VC came back to science to focus on finding better targets faster against cancer

Read Article

Work With Us to Cure Cancer

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.